Sit Investment Associates’s Kindred Biosciences, Inc. KIN Stock Holding History

Sit Investment Associates’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-21,650	Closed	-$108K	–	547
2021 Q1	$108K	Hold	21,650	–	–	﹤0.01%	495
2020 Q4	$93K	Hold	21,650	–	–	﹤0.01%	488
2020 Q3	$93K	Hold	21,650	–	–	﹤0.01%	481
2020 Q2	$97K	Sell	21,650 -56,325	-72%	-$252K	﹤0.01%	483
2020 Q1	$312K	Hold	77,975	–	–	0.01%	403
2019 Q4	$661K	Sell	77,975 -56,400	-42%	-$440K	0.02%	371
2019 Q3	$920K	Buy	134,375 +37,525	+39%	+$275K	0.03%	342
2019 Q2	$807K	Sell	96,850 -19,500	-17%	-$168K	0.02%	361
2019 Q1	$1.07M	Buy	116,350 +58,800	+102%	+$597K	0.03%	331
2018 Q4	$630K	Hold	57,550	–	–	0.02%	372
2018 Q3	$803K	Sell	57,550 -13,050	-18%	-$177K	0.02%	352
2018 Q2	$752K	Buy	+70,600	New	+$688K	0.02%	379

Other funds holding KIN

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

Sit Investment Associates's KIN Position: Q2 2021 in Review

Sit Investment Associates sold out of Kindred Biosciences, Inc. (KIN) in Q2 2021, closing a stake of 21,650 shares — an estimated $108K sold.

Sit Investment Associates first reported a position in KIN in Q2 2018 and held it in 12 quarters. The position peaked at $1.07M in Q1 2019. 87 funds tracked by Wall St. Rank hold KIN as of Q2 2021.

Sit Investment Associates reported no remaining Kindred Biosciences, Inc. position as of Q2 2021 after selling out during the quarter.
Sit Investment Associates sold 21,650 Kindred Biosciences, Inc. shares in Q2 2021, an estimated $108K.
Sit Investment Associates first reported a position in Kindred Biosciences, Inc. in Q2 2018 and held it in 12 quarters.
Sit Investment Associates's Kindred Biosciences, Inc. position peaked at $1.07M in Q1 2019.
87 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q2 2021.

Based on Sit Investment Associates's 13F filing for Q2 2021, filed 13 Aug 2021.